Management of Refractory Constipation

Initial Therapeutic Approach

The American Gastroenterological Association recommends adding a stimulant laxative, such as bisacodyl 5-10 mg daily or senna 8.6-17.2 mg daily, for short-term use or as rescue therapy, after failure of fiber supplements, lactulose, and PEG 1, 2
Bisacodyl should be initiated at a dose of 5 mg daily, titrating up to 10 mg daily based on response, with common side effects including abdominal pain, cramping, and diarrhea 3
Senna is an alternative stimulant option, starting with 8.6-17.2 mg daily, with a similar side effect profile to bisacodyl 1, 2

Magnesium oxide can be added or substituted, starting with 400-500 mg daily, titrating up as needed, with a critical caveat to avoid use in patients with renal insufficiency due to risk of hypermagnesemia 1, 2, 3

The American Gastroenterological Association recommends prescription intestinal secretagogues, such as lubiprostone, linaclotide, or plecanatide, for patients who fail over-the-counter therapies 5, 3
Lubiprostone, a chloride channel-2 activator, is dosed at 24 μg twice daily, with potential benefits for abdominal pain, but may cause diarrhea in a subset of patients 5, 3
Linaclotide, a guanylate cyclase-C agonist, is started at 72-145 μg daily, with potential benefits for abdominal pain, but may cause diarrhea as a limiting side effect 5, 3

It is essential to optimize existing therapies before escalating, including verifying adequate fluid intake and encouraging physical activity to stimulate bowel motility 4, 6
Combination therapy with stimulant laxatives and ongoing osmotic agents may be effective, rather than using stimulant laxatives as monotherapy 1, 2